Monitoring secretagogin expression at the transcription (RNA) level, we found that it robustly decreased already in Braak III–IV stage subjects and further diminished in severe Alzheimer’s disease (Fig. 8h). The gene discussed is SCGN; the disease is Alzheimer disease.